Harmo Brain vs Prevagen: Which Formula Has the Better Evidence?
Prevagen contains one jellyfish protein with a court order and a single company-funded trial that found no overall benefit. Harmo Brain contains three ingredients, each with independent peer-reviewed human data. This comparison breaks down the labels, the studies and the lawsuits.
Written and fact-checked by RecallPath Editorial Team. Last updated: . About our editorial process.
- Prevagen: 10 mg apoaequorin + 50 mcg vitamin D. One company-funded trial (n=218) found no statistically significant benefit in the full study population.
- Harmo Brain: 250 mg citicoline + 300 mg bacopa + 100 mg phosphatidylserine. Each ingredient has independent peer-reviewed RCTs.
- Regulatory: FDA warned Prevagen in 2012. FTC sued in 2017. A jury found eight marketing claims unsupported in 2024. A court ordered Quincy Bioscience to cease those claims in December 2024.
- Safety: Both are generally well tolerated. Prevagen may cause headache or dizziness. Harmo Brain contains cholinergics and phospholipids with known interaction profiles.
What is in each bottle
| Label item | Harmo Brain | Prevagen (Regular Strength) |
|---|---|---|
| Active ingredients | 3 | 2 |
| Primary actives | Citicoline 250 mg, Bacopa monnieri 300 mg, Phosphatidylserine 100 mg | Apoaequorin 10 mg, Vitamin D3 50 mcg |
| Proprietary blend | No | No |
| Caffeine / stimulants | No | No |
| Standardization | Bacopa standardized for bacosides | Not stated |
| Peer-reviewed RCTs | Multiple independent studies per ingredient | One company-funded trial (Madison Memory Study) |
| BBB penetration data | Citicoline and phosphatidylserine cross the BBB | No evidence apoaequorin crosses the BBB |
The evidence for Harmo Brain
Each ingredient in Harmo Brain has at least one independent peer-reviewed RCT with publicly available data.
Citicoline (250 mg). Nakazaki et al. (J Nutr, 2021, PMC8349115) used 500 mg Cognizin in adults with age-associated memory impairment (AAMI, n=100, ages 50-85) over 12 weeks. The citicoline group improved episodic memory on computerized tests. The 250 mg dose in Harmo Brain is half the memory-study dose. It covers attention and mental energy, not full memory support.
Bacopa monnieri (300 mg). Stough et al. (Psychopharmacology, 2001, PMID 11498727) used 300 mg of CDR08 extract standardized for at least 55% bacosides in 46 adults over 12 weeks. The trial found improved delayed word recall and reduced state anxiety. The dose in Harmo Brain matches this trial exactly.
Phosphatidylserine (100 mg). Kato-Kataoka et al. (J Clin Biochem Nutr, 2010, PMID 20492494) used 100 mg daily for six months in 78 elderly adults with memory complaints. The effect was limited to a subgroup with low baseline performance. ConsumerLab notes that soy-derived phosphatidylserine provides a very modest benefit overall.
The evidence for Prevagen
Prevagen relies on a single active ingredient: apoaequorin, a calcium-binding protein originally found in the jellyfish Aequorea victoria. The company uses a recombinant (lab-made) version.
The main clinical evidence is the Madison Memory Study (Moran et al., Adv Mind Body Med, 2016, PMID 26878676). It was a randomized, double-blind, placebo-controlled trial of 218 community-dwelling adults aged 40 to 91 with self-reported memory concerns. Participants took 10 mg of apoaequorin or placebo daily for 90 days.
The result in the full population: No statistically significant difference between the apoaequorin group and the placebo group on the primary cognitive endpoints.
The post-hoc finding: A subgroup of 97 participants with mild subjective cognitive impairments showed an improvement in verbal learning. The apoaequorin group improved by 10.86% versus 3.79% in the placebo group. This was a post-hoc analysis. It was not pre-specified in the trial protocol and was not adjusted for multiple comparisons. The FTC later cited this as a classic example of data mining.
Bioavailability concerns: Apoaequorin is a protein with a molecular weight of approximately 22,000 Da. An in vitro digestion study found that more than 90% of apoaequorin is broken down by pepsin in the stomach within 30 seconds (Moran, Regul Toxicol Pharmacol, 2014). There is no published evidence that intact apoaequorin crosses the blood-brain barrier. The NIH LiverTox database states: “These findings were questioned later because of the lack of evidence that apoaequorin is absorbed orally or can cross the blood-brain barrier.”
The regulatory record
2012: The FDA sent Quincy Bioscience a warning letter. The agency classified synthetic apoaequorin as an “unapproved new drug” and cited the company for failure to report adverse events.
2017: The FTC and the New York Attorney General sued Quincy Bioscience for false and unsubstantiated claims. The complaint stated that the Madison Memory Study “only found a benefit in a small subset of participants and only on certain measures of cognitive function.”
2020: Quincy settled the class-action portion. The company agreed to stop certain claims and pay cash refunds to purchasers.
2024: After a 12-day jury trial, the jury found that all eight challenged marketing statements lacked competent and reliable scientific evidence. Two statements were found “materially misleading”: “Prevagen reduces memory problems associated with aging” and “Prevagen is clinically shown to reduce memory problems associated with aging.”
December 2024: A U.S. District Court ordered Quincy Bioscience to cease the use of all eight challenged marketing statements nationwide. The FTC stated: “Companies should take note and remember that health claims need to be backed up by reliable scientific evidence.”
Dosage and form
Harmo Brain uses three capsules or one serving per day depending on the batch. The doses are transparent and match published trials. Prevagen uses one capsule per day at 10 mg (Regular), 20 mg (Extra Strength) or 40 mg (Professional). The 10 mg dose is the one tested in the Madison Memory Study.
The vitamin D3 in Prevagen (50 mcg, or 2,000 IU) is more than twice the daily requirement for most adults. It is below the Upper Tolerable Intake Level but adds little unique value. A standard vitamin D supplement costs a fraction of the Prevagen price.
Side effects and safety
Harmo Brain warnings
Citicoline is a cholinergic. Some users report headache or difficulty sleeping, especially if taken late in the day. Take it in the morning. Phosphatidylserine has a theoretical bleeding risk. It can interact with warfarin, aspirin and other anticoagulants. Show the label to your doctor if you take any blood thinner.
Prevagen warnings
Reported adverse effects include headache, dizziness, nausea, memory problems, difficulty sleeping and anxiety. The Merck Manuals note: “Overall, the safety of apoaequorin is not known.” The risk for serious drug interactions is also not known. If you take blood thinners or blood pressure medication, talk to your doctor before starting Prevagen.
Who each formula fits
Choose Harmo Brain if you want a formula with transparent dosing, multiple independent RCTs and ingredients that cross the blood-brain barrier. The 300 mg bacopa dose matches a published memory trial. The 250 mg citicoline supports attention. The 100 mg phosphatidylserine adds modest structural support. Expect 8 to 12 weeks before judging results.
Choose Prevagen if you prefer a single-ingredient formula with minimal stimulant risk and are comfortable with the regulatory history. The evidence for apoaequorin is limited to one company-funded trial with a post-hoc subgroup analysis. The price reflects brand recognition and marketing spend, not ingredient cost.
Neither formula treats dementia or Alzheimer’s disease. Both are dietary supplements. If you have persistent memory loss, confusion with time or place, or trouble completing familiar tasks, see a doctor. Those are not supplement problems.
Frequently Asked Questions
Does Prevagen contain citicoline or bacopa?
No. Prevagen contains apoaequorin and vitamin D3 only. It does not contain citicoline, bacopa monnieri, phosphatidylserine or any other nootropic ingredient with independent peer-reviewed RCTs.
Which formula has more clinical evidence?
Harmo Brain. Each of its three ingredients has at least one independent peer-reviewed RCT. Prevagen has one company-funded trial (Madison Memory Study) that found no statistically significant benefit in the full study population.
Is apoaequorin proven to improve memory?
No. The Madison Memory Study found no statistically significant difference between apoaequorin and placebo in the full population of 218 adults. A post-hoc subgroup analysis of 97 participants showed an improvement in verbal learning, but this was not pre-specified and was not adjusted for multiple comparisons.
Can I take Harmo Brain and Prevagen together?
There is no reason to. The formulas target different mechanisms and there is no published evidence that combining them provides additive benefit. If you choose to stack supplements, show both labels to your doctor.
Which is safer for seniors?
Both are generally well tolerated in healthy adults. Prevagen has a shorter safety record with less independent data. Harmo Brain contains phosphatidylserine, which has a theoretical bleeding risk. Seniors on blood thinners should check with a doctor before using either formula.
Why is Prevagen more expensive?
Brand recognition and marketing spend. Prevagen runs national television advertising. The active ingredients (apoaequorin and vitamin D) are not inherently expensive. Harmo Brain prices vary by retailer but typically undercut Prevagen on a per-ingredient basis.
Does apoaequorin cross the blood-brain barrier?
There is no published evidence that it does. Apoaequorin is a protein with a molecular weight of approximately 22,000 Da. Proteins of this size are typically broken down in the digestive tract. An in vitro study found more than 90% is digested by pepsin within 30 seconds.
What happened in the Prevagen lawsuit?
In December 2024, a U.S. District Court ordered Quincy Bioscience to cease eight marketing statements nationwide. A jury had found all eight lacked scientific support and two were “materially misleading.” The FTC stated the ruling should remind companies that health claims need reliable scientific evidence.
Sources and References
- Moran et al. (2016) — Madison Memory Study, Adv Mind Body Med, PMID 26878676
- Review of Supplements for Dementia — PMC11727725 (Madison Memory Study critique)
- Apoaequorin — Merck Manuals (Professional Version)
- FTC v. Quincy Bioscience — Case Summary
- FTC Statement on Prevagen Lawsuit Win (Dec 2024)
- Nakazaki et al. (2021) — Citicoline RCT, J Nutr, PMID 33978188
- Stough et al. (2001) — Bacopa RCT, Psychopharmacology, PMID 11498727
- Kato-Kataoka et al. (2010) — Phosphatidylserine RCT, J Clin Biochem Nutr, PMID 20492494
- Citicoline — Examine.com
- Bacopa Monnieri — Examine.com
Need help choosing?
RecallPath does not sell supplements. We publish facts for readers over 40.
Email us